We serve Chemical Name:(r)-(+)-1-benzylamino-3-phenoxy-2-propanol CAS:203309-98-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(r)-(+)-1-benzylamino-3-phenoxy-2-propanol
CAS.NO:203309-98-2
Synonyms:(r)-(+)-1-benzylamino-3-phenoxy-2-propanol
Molecular Formula:C16H19NO2
Molecular Weight:257.32800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.49000
Exact Mass:257.14200
LogP:2.60700
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (r)-(+)-1-benzylamino-3-phenoxy-2-propanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(r)-(+)-1-benzylamino-3-phenoxy-2-propanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(r)-(+)-1-benzylamino-3-phenoxy-2-propanol Use and application,(r)-(+)-1-benzylamino-3-phenoxy-2-propanol technical grade,usp/ep/jp grade.
Related News: The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun. (r)-(+)-1-benzylamino-3-phenoxy-2-propanol manufacturer Any drug or medication is composed of two components. (r)-(+)-1-benzylamino-3-phenoxy-2-propanol supplier When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. (r)-(+)-1-benzylamino-3-phenoxy-2-propanol vendor Any drug or medication is composed of two components. (r)-(+)-1-benzylamino-3-phenoxy-2-propanol factory We partner with life science companies of all sizes, drawing on over 20 years of industry experience.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. (r)-(+)-1-benzylamino-3-phenoxy-2-propanol vendor Any drug or medication is composed of two components. (r)-(+)-1-benzylamino-3-phenoxy-2-propanol factory We partner with life science companies of all sizes, drawing on over 20 years of industry experience.
